Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2012
06/07/2012US20120142658 Therapeutical use of ternary complexes of valproic acid
06/07/2012US20120142655 Novel crystal form of an organic compound and process for the preparation thereof
06/07/2012US20120142654 Prognostic marker for mamma carcinoma
06/07/2012US20120142642 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142641 Targetted drug delivery to the bone
06/07/2012US20120142640 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
06/07/2012US20120142639 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142637 Prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-(1h)- one and derivatives thereof
06/07/2012US20120142636 Novel glucokinase activators and methods of using same
06/07/2012US20120142634 Method of Treating Cancer with a Combination of a Proteasome Inhibitor and Salubrinal
06/07/2012US20120142625 Substituted Purine And 7-Deazapurine Compounds
06/07/2012US20120142624 Akt phosphorylation at ser473 as an indicator for taxane-based chemotherapy
06/07/2012US20120142622 Stambomycin and derivatives, their production and their use as drugs
06/07/2012US20120142620 Core 2 glcnac-t inhibitors
06/07/2012US20120142617 Antiviral therapeutic agents
06/07/2012US20120142616 Antineoplastic Hydrogels, and Enzyme-Instructed Preparations Thereof
06/07/2012US20120142614 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
06/07/2012US20120142612 Cytokine protein family
06/07/2012US20120142607 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
06/07/2012US20120142606 Tumor targeting peptides, therapeutic and diagnostic compositions compressing the peptides
06/07/2012US20120142590 Methods and Compounds Regulating the Erythroid Response to Iron Deficiency
06/07/2012US20120142585 Leptin antagonist and methods of use
06/07/2012US20120142584 Novel transporter constructs and transporter cargo conjugate molecules
06/07/2012US20120142071 Thymidine Kinase Mutants
06/07/2012US20120141618 Process for preparing integral olive juice, using this process to obtain the composition and its application in the field of cosmetics and nutrition
06/07/2012US20120141610 Novel Topical Composition Of Sarracenia Purpurea (Pitcher Plant)
06/07/2012US20120141606 Sigma ligands for the prevention or treatment of pain induced by chemotherapy
06/07/2012US20120141605 Pyrazoloanthrone and derivatives thereof for treatment of cancer and excess androgen states
06/07/2012US20120141604 Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers
06/07/2012US20120141603 Methods and compositions for lung cancer prognosis
06/07/2012US20120141602 Systems containing magnetic nanoparticles and polymers, such as nanocomposites and ferrofluids, and applications thereof
06/07/2012US20120141594 Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy, and anti-cancer activity and methods of use
06/07/2012US20120141591 Drug Delivery Nanocarriers Targeted by Landscape Phage
06/07/2012US20120141579 Cytotoxic T Lymphocyte Inducing Immunogens for Prevention Treatment and Diagnosis of Cancer
06/07/2012US20120141578 Compositions and methods relating to proliferative diseases
06/07/2012US20120141573 Cell Lines That Secrete Anti-Angiogenic Antibody-Scaffolds and Soluble Receptors and Uses Thereof
06/07/2012US20120141560 Tumor and infectious disease therapeutic compositions
06/07/2012US20120141551 Aptamer bioconjugate drug delivery device
06/07/2012US20120141550 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
06/07/2012US20120141540 Drug Delivery System
06/07/2012US20120141538 Modulators of the cx3cri receptor and therapeutic uses thereof
06/07/2012US20120141537 Enhancing t cell activation using altered mhc-peptide ligands
06/07/2012US20120141524 Ethanol extract of antrodia camphorata for inducing apoptosis and preparation method thereof
06/07/2012US20120141517 Novel immunotherapy against several tumors including neuronal and brain tumors
06/07/2012US20120141516 Compositions and methods for inducing an immune response
06/07/2012US20120141514 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/07/2012US20120141513 Deuterated fingolimod
06/07/2012US20120141512 Method of increasing immunological effect
06/07/2012US20120141510 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141509 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141508 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141506 Treatment of non-proliferative cystic disease
06/07/2012US20120141505 Cd19-ligand and use
06/07/2012US20120141501 Pharmaceutical Composition Containing Antagonist of EGF Family Ligand as Component
06/07/2012US20120141500 Antibodies Against Human Angiopoietin 2
06/07/2012US20120141499 Specific binding agents of human angiopoietin-2
06/07/2012US20120141498 Use of pkc isozymes for diagnosis and treatment of neuroblastoma
06/07/2012US20120141496 Iap bir domain binding compounds
06/07/2012US20120141495 Method for suppressing tumor growth by blocking fibroblast growth factor receptor, and method for diagnosing malignant neoplasms
06/07/2012US20120141494 Fully human antibodies against human 4-1bb
06/07/2012US20120141491 Methods and compositions for the treatment of cancers and pathogenic infections
06/07/2012US20120141490 Antibodies That Bind Selectively To P25 And Uses Therefor
06/07/2012US20120141488 Novel g protein coupled receptor protein and use thereof
06/07/2012US20120141486 Human monoclonal antibody
06/07/2012US20120141481 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders
06/07/2012US20120141479 Histone Deacetylase Inhibitors Sensitize Cancer Cells To Epidermal Growth Factor Inhibitors
06/07/2012US20120141478 Compositions and methods for delivering anti-activated ras antibodies
06/07/2012US20120141476 FcGammaRIIB Specific Antibodies and Methods of Use Thereof
06/07/2012US20120141473 Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins
06/07/2012US20120141471 Methods of Inhibiting Metastasis from Cancer
06/07/2012US20120141470 T cell inhibitory receptor compositions and uses thereof
06/07/2012US20120141469 Cripto antagonism of activin and tgf-b signaling
06/07/2012US20120141467 Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma
06/07/2012US20120141464 Binding member for gm-csf receptor
06/07/2012US20120141462 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
06/07/2012US20120141451 Fibroblast growth factor receptor-derived peptides binding to ncam
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141446 Oral Nutritional Supplement Delivery System
06/07/2012US20120141434 Methods for Selecting Expanded Stem Cell Populations
06/07/2012US20120141427 Attenuated Strain of Myxoma Virus for Use as an Oncolytic Drug
06/07/2012US20120141426 Reovirus for the Treatment of Cellular Proliferative Disorders
06/07/2012US20120141421 Liquid viral formulations
06/07/2012US20120141418 Treatment of Melanoma Using HSV Mutant
06/07/2012US20120141416 Multimeric peptide conjugates and uses thereof
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012US20120141411 Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
06/07/2012US20120141392 Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor
06/07/2012US20120141382 Aptamer modulators of complement protein c3 and biologically active proteolytic products thereof
06/07/2012US20120141380 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
06/07/2012US20120141379 Microspheres for active embolization
06/07/2012US20120141377 Compositions and methods for treating cancer
06/07/2012US20120141376 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
06/07/2012US20120141374 Methods and compositions for targeting hepsin
06/07/2012US20120141372 RS7 Antibodies
06/07/2012US20120141371 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
06/07/2012CA2824724A1 Methods and systems for spatially identifying abnormal cells
06/07/2012CA2821515A1 Anti-ngf compositions and use thereof
06/07/2012CA2820550A1 Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredient
06/07/2012CA2819829A1 Compositions and methods for treating foxp3+ treg related diseases
06/07/2012CA2819822A1 Oxazolo [5,4-b] pyridin-5-yl compounds and their use for the treatment of cancer
1 ... 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 ... 2211